Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society
Main Content

MDS-ES Management of Advanced Parkinson’s Disease with Infusion Therapies

Join us live on November 12-13, 2020 from 15:00 – 17:50 CET for live streaming of lectures and live interactive discussions with faculty on both days.


Course Directors

Klaus Seppi, MD
Angelo Antonini, MD, PhD


Regina Katzenschlager, MD
Tove Henriksen, MD
Werner Poewe, MD
Cristian Falup-Pecurariu, MD, PhD
K. Ray Chaudhuri, MD, FRCP, DSc

Course Description

This course will provide the theoretical education and practical experience in the management of pump-based treatments for advanced Parkinson’s disease (Levodopa-carbidopa intestinal gel and apomorphine). The course includes lectures on patient selection, effects, side effects and practical management, as well as an interactive Q&A session with the experts.

Interactive Components

Join us for live interaction with the expert faculty on both course days.

Thursday, November 12 (17:05 – 17:50 CET): Ask the Experts Panel Discussion with Moderated Q&A

Friday, November 13  (16:35 – 17:05 CET): Challenging Cases from Faculty

Friday, November 13 (17:05 – 17:45 CET): Ask the Experts Panel Discussion with Moderated Q&A

Target Audience

Clinicians, post-doctoral fellows, medical residents, medical students, and allied health professionals with an interest in infusion therapies for advanced Parkinson's Disease.

Learning Objectives 
  1. Describe the theoretical evidence supporting CDS-based treatment
  2. List criteria and demonstrate process for selecting patients for pump-based PD treatment
  3. Describe the effects of pump treatments on motor, non-motor symptoms and quality of life
  4. Explain and demonstrate management of pump-based therapies
  5. Identify possible side effects and complications of pump therapies, including management of these complications​
Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The International Parkinson and Movement Disorder Society designates this activity for a maximum of  5.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.

Satisfactory Completion:

Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.

Content Validity Statement:

All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.

Disclosure of Financial Relationships:

All individuals in control of content for this webinar are required to disclose all relevant financial relationships with commercial interests as defined by the ACCME. Disclosure information can be found here.